GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Net Issuance of Preferred Stock

Vicplas International (SGX:569) Net Issuance of Preferred Stock : S$0.0 Mil (TTM As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Vicplas International's net issuance of preferred for the six months ended in Jan. 2024 was S$0.0 Mil. The number is 0, which means that Vicplas International has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Vicplas International's net issuance of preferred for the trailing twelve months (TTM) ended in Jan. 2024 was S$0.0 Mil.


Vicplas International Net Issuance of Preferred Stock Historical Data

The historical data trend for Vicplas International's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Net Issuance of Preferred Stock Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vicplas International Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicplas International Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Vicplas International's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines